European Primary Care Cardiovascular Society

Hypertension - Can we agree on diagnostic and therapeutic thresholds?

Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Prof. Richard McManus, prof. Richard Hobbs and prof. Christos Lionis
Three professors discuss how best to measure blood pressure, when to call it hypertension, and once hypertension is diagnosed, what BP target to aim for, based on the latest scientific insights.

EPCCS 2018 Three professors discuss how best to measure blood pressure, when to call it hypertension, and once hypertension is diagnosed, what BP target to aim for, based on the latest scientific insights.

Even normotensive young blacks have a higher risk of hypertension than whites

July 19, 2018 - Thomas SJ, et al. - J Am Heart Assoc. 2018

Black individuals have a significantly higher risk for hypertension compared with whites, from young adulthood through middle age, irrespective of BP before the age of 30 years.

The cardiovascular challenge for primary care in diabetes

July 10, 2018 - Prof. Richard Hobbs - Oxford, UK
Prof. Hobbs stresses  the importance of CVRM in primary care and how to manage this risk beyond glucose control.

Prof. Hobbs stresses the importance of CVRM in primary care and how to manage this risk beyond glucose control.

Exaggerated BP response to exercise in hypertensives with controlled resting BP

June 20, 2018 - Chant B, et al. - Hypertension 2018

BP responses to exercise are similar in treated–controlled, treated-uncontrolled, and untreated hypertensives but higher compared with normotensives.

Risk of dementia increases with hypertension duration in mid-life

June 19, 2018 - Abell JG et al. - Eur Heart J 2018

Individuals with hypertension at mid-life, defined as SBP ≥130 mmHg at the age of 50, have an increased risk of dementia, which is proportional to the duration of the exposure to hypertension

New 2018 ESC/ESH Guidelines for treatment of hypertension - a first look

June 14, 2018 - news

Before publication later this year, a first look at the new 2018 ESC/ESH Guidelines of hypertension was presented. One of the key messages was the unchanged definition of hypertension of BP >140/90 mmHg.

High CV risk in obese women even in the absence of metabolic abnormalities

June 13, 2018 - Eckel N, et al. - Lancet Diab Endocrin 2018

CV risk is high in obese women without metabolic abnormalities, as well as in women with hypertension, diabetes or hypercholesterolemia, independently of their body mass index.

What’s the evidence, why do guidelines differ, and what should the GP do?

EPCCS CV Summit 2018

Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Prof. Richard McManus, Oxford, United Kingdom
A recording of the lecture by prof. McManus, in which he considered why guidelines do not agree on BP targets, and how GPs can best manage hypertension.

EPCCS 2018 A recording of the lecture by prof. McManus, in which he considered why guidelines do not agree on BP targets, and how GPs can best manage hypertension.

Folic acid lowered stroke risk in hypertensive patients

May 16, 2018 - Kong X et al. - J Am Coll Cardiol 2018

Patients with hypertension with low platelet counts and high total homocysteine levels, which may promote platelet adherence, had the highest risk of first stroke, and this risk was reduced with folic acid treatment.

Stronger prediction of mortality by ambulatory BP than clinic BP

May 8, 2018 - Banegas JR, et al. - N Engl J Med 2018

24-hour, daytime, and nighttime ambulatory systolic blood pressure measurements were better predictors of all-cause and CV mortality compared with blood pressure measurements in the clinic.

New American guidelines result in more children with hypertension

May 7, 2018 - Sharma AK, et al. - JAMA Pediatr 2018

Based on the new blood pressure definitions for children, the estimated population prevalence of hypertension in individuals aged 5-18 years increased from 11.8% to 14.2%.

BMI trajectories from child to adult affect CV risk factors in mid-adulthood

May 7, 2018 - Buscot M-J, et al. - Eur Heart J 2018

Obesity in childhood that persists or worsens during adulthood is associated with higher risks of developing hypertension, T2DM, and dyslipidemia.